Display options
Cite
Messer L, Alsaleh G, Georgel P, et al. Homozygosity for the V377I mutation in mevalonate kinase causes distinct clinical phenotypes in two sibs with hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS). RMD Open. 2016;2(1):e000196doi: 10.1136/rmdopen-2015-000196.
Messer, L., Alsaleh, G., Georgel, P., Carapito, R., Waterham, H. R., Dali-Youcef, N., Bahram, S., & Sibilia, J. (2016). Homozygosity for the V377I mutation in mevalonate kinase causes distinct clinical phenotypes in two sibs with hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS). RMD open, 2(1), e000196. https://doi.org/10.1136/rmdopen-2015-000196
Messer, Laurent, et al. "Homozygosity for the V377I mutation in mevalonate kinase causes distinct clinical phenotypes in two sibs with hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS)." RMD open vol. 2,1 (2016): e000196. doi: https://doi.org/10.1136/rmdopen-2015-000196
Messer L, Alsaleh G, Georgel P, Carapito R, Waterham HR, Dali-Youcef N, Bahram S, Sibilia J. Homozygosity for the V377I mutation in mevalonate kinase causes distinct clinical phenotypes in two sibs with hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS). RMD Open. 2016 Mar 07;2(1):e000196. doi: 10.1136/rmdopen-2015-000196. eCollection 2016. PMID: 26977311; PMCID: PMC4785531.
Copy Download .nbib Format: NLM
Share it on

RMD Open. 2016 Mar 07;2(1):e000196. doi: 10.1136/rmdopen-2015-000196. eCollection 2016.

Homozygosity for the V377I mutation in mevalonate kinase causes distinct clinical phenotypes in two sibs with hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS).

RMD open

Laurent Messer, Ghada Alsaleh, Philippe Georgel, Raphael Carapito, Hans R Waterham, Nassim Dali-Youcef, Siamak Bahram, Jean Sibilia

Affiliations

  1. Service de Rhumatologie , Hôpitaux Civils de Colmar , Colmar , France.
  2. Faculté de Médecine, Laboratoire d'ImmunoRhumatologie Moléculaire , INSERM UMR_S1109, LabEx Transplantex, Centre de Recherche d'Immunologie et d'Hématologie, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg , Strasbourg , France.
  3. Laboratory Genetic Metabolic Diseases (F0-222), Departments of Clinical Chemistry and Pediatrics , Academic Medical Center, University of Amsterdam , Amsterdam , The Netherlands.
  4. Laboratoire de Biochimie et de Biologie Moléculaire, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC)/CNRS UMR 7104/INSERM U 964/Université de Strasbourg, Illkirch, France.
  5. Faculté de Médecine, Laboratoire d'ImmunoRhumatologie Moléculaire, INSERM UMR_S1109, LabEx Transplantex, Centre de Recherche d'Immunologie et d'Hématologie, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France; Service de Rhumatologie, Centre National de Référence pour les Maladies Systémiques Autoimmunes Rares, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

PMID: 26977311 PMCID: PMC4785531 DOI: 10.1136/rmdopen-2015-000196

Abstract

OBJECTIVE: Mevalonate kinase (MVK) deficiency is a rare autosomal recessive auto-inflammatory disorder characterised by recurring episodes of fever associated with multiple non-specific inflammatory symptoms and caused by mutations in the MVK gene. The phenotypic spectrum is wide and depends mostly on the nature of the mutations. Hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS) is a relatively mild presentation and predominantly associated with a c.1129G>A (p.V377I) mutation in the MVK gene. We report cases of two sisters homozygous for this mutation but exhibiting distinct (symptomatic vs asymptomatic) phenotypes.

METHODS: Patient history was obtained; physical and clinical examination and laboratory tests were performed; lipopolysaccharide (LPS) response of peripheral blood mononuclear cells was quantified.

RESULTS: Low MVK enzymatic activity is not necessarily associated with inflammatory symptoms. Increased inflammatory cytokine secretion in response to LPS is associated with symptomatic MVK deficiency.

CONCLUSIONS: Individuals who are homozygous for the common p.V377I mutation in the MVK gene may not display the characteristic inflammatory episodes diagnostic of MKD and thus may be lost for correct and timely diagnosis.

Keywords: Disease Activity; Gene Polymorphism; Inflammation

References

  1. Clin Exp Rheumatol. 2000 Jul-Aug;18(4):525-32 - PubMed
  2. J Clin Immunol. 2015 Apr;35(3):249-53 - PubMed
  3. Pediatrics. 2003 Feb;111(2):258-61 - PubMed
  4. JIMD Rep. 2016;27:33-8 - PubMed
  5. Arthritis Rheum. 2003 Sep;48(9):2645-51 - PubMed
  6. Ann Rheum Dis. 2015 May;74(5):799-805 - PubMed
  7. Blood. 1995 Jun 15;85(12):3586-93 - PubMed
  8. Clin Immunol. 2013 Jun;147(3):197-206 - PubMed
  9. Hum Mol Genet. 2002 Dec 1;11(25):3115-24 - PubMed
  10. Eur J Pediatr. 1988 Dec;148(3):250-2 - PubMed
  11. Eur J Hum Genet. 2003 Feb;11(2):196-200 - PubMed
  12. Nat Genet. 1999 Jun;22(2):178-81 - PubMed
  13. J Biol Chem. 2014 Oct 3;289(40):27757-65 - PubMed
  14. Clin Immunol. 2013 Jun;147(3):242-75 - PubMed
  15. Neurology. 2004 Mar 23;62(6):994-7 - PubMed
  16. Medicine (Baltimore). 1994 May;73(3):133-44 - PubMed

Publication Types